Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Xbrane Biopharma AB

Closing information (x1000 NOK)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 54,502 Less Arrow 0 Equal arrow 0
Financial expenses 2,172 More Arrow 2,578 Less Arrow 805
Earnings before taxes -159,399 Less Arrow -178,686 Less Arrow -236,785
EBITDA -150,188 Less Arrow -164,194
Total assets 653,167 More Arrow 671,369 Less Arrow 485,839
Current assets 485,749 More Arrow 547,107 Less Arrow 392,308
Current liabilities 223,774 Less Arrow 214,224 Less Arrow 197,989
Equity capital 401,907 More Arrow 421,043 Less Arrow 269,975
- share capital 5,832 Less Arrow 5,475 Less Arrow 3,621
Employees (average) 68 Less Arrow 50 Less Arrow 39

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 61.5% More Arrow 62.7% Less Arrow 55.6%
Turnover per employee 802 Less Arrow 0 Equal arrow 0
Profit as a percentage of turnover -292.5%
Return on assets (ROA) -24.1% Less Arrow -26.2% Less Arrow -48.6%
Current ratio 217.1% More Arrow 255.4% Less Arrow 198.1%
Return on equity (ROE) -39.7% Less Arrow -42.4% Less Arrow -87.7%
Change turnover 54,502 Less Arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 18 Less Arrow 11 Less Arrow 3
Chg. No. of employees % 36% Less Arrow 28% Less Arrow 8%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.